---
document_datetime: 2023-09-21 19:46:19
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/atryn-epar-all-authorised-presentations_en.pdf
document_name: atryn-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8000626
conversion_datetime: 2025-12-26 12:01:49.853258
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical Form              | Route of Administration   | Packaging    | Package size   |
|-----------------|-----------------|------------|----------------------------------|---------------------------|--------------|----------------|
| EU/1/06/355/001 | ATryn           | 1750 IU    | Powder for solution for infusion | Intravenous use           | vial (glass) | 1 vial         |
| EU/1/06/355/002 | ATryn           | 1750 IU    | Powder for solution for infusion | Intravenous use           | vial (glass) | 10 vials       |
| EU/1/06/355/003 | ATryn           | 1750 IU    | Powder for solution for infusion | Intravenous use           | vial (glass) | 25 vials       |

## 1/1 Invented name Strength Pharmaceutical Form ATryn 1750 IU Powder for solution for infusion ATryn 1750 IU Powder for solution for infusion ATryn 1750 IU Powder for solution for infusion Medicinal product no longer authorised